Hans Veerman

About

Hans Veerman is a leading researcher in urologic oncology, specializing in prostate cancer imaging and surgical outcomes. His work centers on leveraging advanced imaging modalities—particularly prostate-specific membrane antigen (PSMA) PET/CT and multiparametric MRI—to improve risk stratification and treatment personalization for localized prostate cancer. Veerman’s major contributions include demonstrating that intraprostatic maximum standardized uptake values (SUVmax) on PSMA PET/CT are significantly associated with biochemical recurrence after robot-assisted radical prostatectomy (RARP), with his most cited paper (27 citations) establishing this link. He also developed and validated prediction models for urinary incontinence risk and extraprostatic extension, directly aiding shared decision-making and surgical planning. Notably, his standardized method for measuring membranous urethral length on MRI (17 citations) has enhanced reproducibility in functional outcome studies. With over 120 total citations across his top ten papers, Veerman’s work bridges imaging biomarkers and clinical outcomes, offering tangible tools for reducing post-surgical complications and improving oncological control. His research is instrumental for clinicians and researchers aiming to refine prostate cancer management through precision imaging and individualized risk assessment.

Research Focus

Key Achievements

Top Papers

1. 1
   Standardised uptake values as determined on prostate‐specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer

   27 citations · 2022
2. 2
   Individual risk prediction of urinary incontinence after prostatectomy and impact on treatment choice in patients with localized prostate cancer

   18 citations · 2021
3. 3
   A standardized method to measure the membranous urethral length (MUL) on MRI of the prostate with high inter- and intra-observer agreement

   17 citations · 2022
4. 4
   Higher Preoperative Maximum Standardised Uptake Values (SUVmax) Are Associated with Higher Biochemical Recurrence Rates after Robot-Assisted Radical Prostatectomy for [68Ga]Ga-PSMA-11 and [18F]DCFPyL Positron Emission Tomography/Computed Tomography

   14 citations · 2023
5. 5
   The detection rate of apical tumour involvement on preoperative MRI and its impact on clinical outcomes in patients with localized prostate cancer

   10 citations · 2021
6. 6
   Intraoperative Strategies to Reduce Catheter-Related Bladder Discomfort in the Early Postoperative Period after Robot-Assisted Radical Prostatectomy

   9 citations · 2021
7. 7
   Surgical and Functional Outcomes of Bladder Neck Incision for Primary Vesico-Urethral Anastomosis Stricture after Robot-assisted Radical Prostatectomy are Influenced by the Presence of Pre- or Postoperative Radiotherapy

   9 citations · 2022
8. 8
   The oncological characteristics of <scp>non‐prostate‐specific membrane antigen (PSMA)‐expressing</scp> primary prostate cancer on preoperative <scp>PSMA</scp> positron emission tomography/computed tomography

   9 citations · 2022
9. 9
   External Validation of a Prediction Model for Side-specific Extraprostatic Extension of Prostate Cancer at Robot-assisted Radical Prostatectomy

   8 citations · 2022
10. 10
    3D-Reconstructed Contact Surface Area and Tumour Volume on Magnetic Resonance Imaging Improve the Prediction of Extraprostatic Extension of Prostate Cancer

    8 citations · 2022

Key Collaborators

Contact & Links